> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OMB Info Collection on Drug Registration
- URL: https://www.fdaweb.com/omb-info-collection-on-drug-registration/
- Published: 2021-10-26T12:00:00.000Z
- Updated: 2026-09-14T17:20:11.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150446

*Federal Register* notice: FDA has submitted to OMB an information collection revision entitled “Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution — 21 CFR Part 207” (OMB Control Number 0910-0045). The collection was revised to include the collection of certain information required by the Coronavirus Aid, Relief, and Economic Security (CARES) Act. For example, Section 3112(e) of the CARES Act amended section 510(j) of the FD&C Act to require that registrants under must annually report the amount of each drug listed that was manufactured, prepared, propagated, compounded, or processed by such person for commercial distribution. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-23395.pdf?ref=fdaweb.com).